Skip to main content

Table 2 Results of health-related quality of life measurement at six months in patients who had complete follow-up at twelve and twenty-four months (n = 31) or were lost to follow-up (dead = 9, no reply = 11)a

From: A prospective longitudinal multicentre study of health related quality of life in ICU survivors with COPD

Parameters

Complete follow-up

(n = 31)

Lost to follow-up

  

Dead ( n = 9)

No reply ( n = 11)

EQ-5D

0.66 (0.62 to 0.80)

0.62

-0.02 (-0.17 to 0.74)

0.22

0.55 (0.26 to 0.73)

0.51

EQ-VAS

50 (40 to 60)

51.1

39 (5 to 70)

36

60 (43 to 73)

55

PF

45 (25 to 65)

45.5

18 (3 to 33)*

21

35 (10 to 45)

34

RP

25 (0 to 75)

37.5

0 (0 to 25)

18

0 (0 to 33)

21

BP

47 (22 to 100)

53.6

22 (10 to 52)

35

41 (22 to 52)

46

GH

40 (25 to 52)

43.1

23 (10 to 40)

31

44 (30 to 67)

49

VT

45 (35 to 55)

47.0

30 (15 to 48)

34

50 (35 to 60)

50

SF

75 (38 to 100)

68.2

38 (13-63)*

38

50 (38 to 88)

57

RE

83 (0 to 100)

58.3

0 (0 to 42)

23

83 (0 to 100)

60

MH

68 (48 to 88)

66.0

58 (24 to 90)

56

72 (40 to 80)

60

  1. aBP, bodily pain; EQ-5D, EuroQoL 5 Dimension; EQ-VAS, EuroQoL Visual Analogue Scale; GH, general health; MH, mental health; PF, physical functioning ; RE, role emotional; RP, role physical; SF, social functioning; VT, vitality. Values are medians (interquartile ranges) and means. *P < 0.05 compared to patients with complete follow-up.